TY - JOUR
T1 - Functional analysis of RUNX2 mutations in Japanese patients with cleidocranial dysplasia demonstrates novel genotype-phenotype correlations
AU - Yoshida, Taketoshi
AU - Kanegane, Hirokazu
AU - Osato, Motomi
AU - Yanagida, Masatoshi
AU - Miyawaki, Toshio
AU - Ito, Yoshiaki
AU - Shigesada, Katsuya
N1 - Funding Information:
We thank the many patients and their families for their cooperation. We are grateful to Drs. N. Okamoto (Osaka Medical Center and Research Institute for Maternal and Child Health), T. Momoi (Japanese Red Cross Society Wakayama Medical Center), H. Ohashi and H. Motizuki (Saitama Children's Medical Center), Y. Ito and Y. Makita (Asahikawa medical college), T. Nagai (Dokkyo Medical Koshigaya School), K. Yano (Nayoro City Hospital), Y. Tanaka (Tokyo Dental University Ichikawa Hospital), S. Nishimaki (Yokohama City University School of Medicine), H. Yamakawa (Yokohama Municipal Citizen's Hospital), S. Teramoto (Fuji City Central Hospital), S. Tamai (Yamato City Hospital), Y. Nishi (Hiroshima Red Cross and Atomic-Bomb Survivors Hospital), N. Yasui (Osaka University Medical School), N. Natsume (Aichi-Gakuin University), K. Takahashi (Kyoto University), K. Kouzai (Hiroshima University), T. Fujiwaki (Matsue Red Cross Hospital), K. Sueishi (Suidobashi Hospital), and Y. Adachi (Toyama Medical and Pharmaceutical University) for providing clinical data and blood samples from patients with CCD. We are deeply indebted to Dr. Yue Wang (Toyama Medical and Pharmaceutical University) for technical assistance and Drs. T. Momoi and N. Okamoto for critical discussion. We also thank Drs. T. Komori (Osaka University), P. P. Liu (National Human Genome Institute), and N. A. Speck (Dartmouth University) for sharing their valuable observations on Cbfb transgenic mice before publication. This work was supported, in part, by Grants-in-Aid 12213064 and 13214052 for Priority Areas in Cancer Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to K.S.).
PY - 2002
Y1 - 2002
N2 - Cleidocranial dysplasia (CCD) is an autosomal dominant heritable skeletal disease caused by heterozygous mutations in the osteoblast-specific transcription factor RUNX2;. We have performed mutational analysis of RUNX2 on 24 unrelated patients with CCD. In 17 patients, 16 distinct mutations were detected in the coding region of RUNX2: 4 frameshift, 3 nonsense, 6 missense, and 2 splicing mutations, in addition to 1 polymorphism. The missense mutations were all clustered within the Runt domain, and their protein products were severely impaired in DNA binding and transactivation. In contrast, two RUNX2 mutants had the Runt domain intact and remained partially competent for transactivation. One criterion of CCD, short stature, was much milder in the patients with the intact Runt domain than in those without. Furthermore, a significant correlation was found between short stature and the number of supernumerary teeth. On the one hand, these genotype-phenotype correlations highlight a general, quantitative dependency, by skeleto-dental developments, on the gene dosage of RUNX2, which has hitherto been obscured by extreme clinical diversities of CCD; this gene-dosage effect is presumed to manifest on small reductions in the total RUNX2 activity, by approximately one-fourth of the normal level at minimum. On the other hand, the classic CCD phenotype, hypoplastic clavicles or open fontanelles, was invariably observed in all patients, including those with normal height. Thus, the cleidocranial bone formation, as mediated by intramembranous ossification, may require a higher level of RUNX2 than does skeletogenesis (mediated by endochondral ossification), as well as odontogenesis (involving still different complex processes). Overall, these results suggest that CCD could result from much smaller losses in the RUNX2 function than has been envisioned on the basis of the conventional haploinsufficiency model.
AB - Cleidocranial dysplasia (CCD) is an autosomal dominant heritable skeletal disease caused by heterozygous mutations in the osteoblast-specific transcription factor RUNX2;. We have performed mutational analysis of RUNX2 on 24 unrelated patients with CCD. In 17 patients, 16 distinct mutations were detected in the coding region of RUNX2: 4 frameshift, 3 nonsense, 6 missense, and 2 splicing mutations, in addition to 1 polymorphism. The missense mutations were all clustered within the Runt domain, and their protein products were severely impaired in DNA binding and transactivation. In contrast, two RUNX2 mutants had the Runt domain intact and remained partially competent for transactivation. One criterion of CCD, short stature, was much milder in the patients with the intact Runt domain than in those without. Furthermore, a significant correlation was found between short stature and the number of supernumerary teeth. On the one hand, these genotype-phenotype correlations highlight a general, quantitative dependency, by skeleto-dental developments, on the gene dosage of RUNX2, which has hitherto been obscured by extreme clinical diversities of CCD; this gene-dosage effect is presumed to manifest on small reductions in the total RUNX2 activity, by approximately one-fourth of the normal level at minimum. On the other hand, the classic CCD phenotype, hypoplastic clavicles or open fontanelles, was invariably observed in all patients, including those with normal height. Thus, the cleidocranial bone formation, as mediated by intramembranous ossification, may require a higher level of RUNX2 than does skeletogenesis (mediated by endochondral ossification), as well as odontogenesis (involving still different complex processes). Overall, these results suggest that CCD could result from much smaller losses in the RUNX2 function than has been envisioned on the basis of the conventional haploinsufficiency model.
UR - http://www.scopus.com/inward/record.url?scp=0036781942&partnerID=8YFLogxK
U2 - 10.1086/342717
DO - 10.1086/342717
M3 - 学術論文
C2 - 12196916
AN - SCOPUS:0036781942
SN - 0002-9297
VL - 71
SP - 724
EP - 738
JO - American Journal of Human Genetics
JF - American Journal of Human Genetics
IS - 4
ER -